FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Glycoside topics
Rebaudioside
Steviol Glycosides
Osteoporosis
Steoporosis
Aminoglycoside
Adsorption
Crystallin
Liquid Fraction
Critical Point
Chromatograph
Alkoxylate
Alkyl Group
Cycloalkyl
Vitamin D3
Osteopenia

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Glycoside patents



      
           
This page is updated frequently with new Glycoside-related patent applications. Subscribe to the Glycoside RSS feed to automatically get the update: related Glycoside RSS feeds. RSS updates for this page: Glycoside RSS RSS


Date/App# patent app List of recent Glycoside-related patents
07/24/14
20140206856
 Glycoside compound, method for producing thioether, ether, method for producing ether, method for producing glycoside compound, method for producing nucleic acid patent thumbnailnew patent Glycoside compound, method for producing thioether, ether, method for producing ether, method for producing glycoside compound, method for producing nucleic acid
Wherein b, r1, r2, and r3 are as described herein.. .
07/24/14
20140206638
 Pulmonary delivery of aminoglycoside patent thumbnailnew patent Pulmonary delivery of aminoglycoside
The present invention is directed to the administration of aminoglycosides. In particular, the present invention is directed to compositions and methods for the pulmonary administration of aminoglycosides.
07/24/14
20140206631
 Cardiac glycoside analogs in combination with emodin for cancer therapy patent thumbnailnew patent Cardiac glycoside analogs in combination with emodin for cancer therapy
A method and medicine for treating leukemia or other cancer includes administering to a patient diagnosed with leukemia or other cancer a treatment regimen that includes periodic doses of a combination of emodin and digoxin.. .
07/24/14
20140205675
 Horse feed dietary supplement composition derived from chia seed composition patent thumbnailnew patent Horse feed dietary supplement composition derived from chia seed composition
A horse feed dietary supplement composition increases the energy and improves the health and coat of a horse and is formed as a partially defatted seed meal composition that may be supplemented to a horse feed. The composition includes a shelf stable, partially defatted supercritical co2 fluid solvent extracted whole grain flour that is derived from salvia hispanica l.
07/17/14
20140199297
 Triterpene glycoside and triterpene compositions and methods of using same patent thumbnailTriterpene glycoside and triterpene compositions and methods of using same
In the present invention, different strategies are used to improve the bioavailability of triterpene glycosides and triterpenes including, for example, (a) a covalent approach involving modification with polyethylene glycol and (b) a formulation approach involving non-covalent encapsulation in antibody targeted pol(dl-lactic acid) nanoparticles.. .
07/17/14
20140199246
 Stevia composition patent thumbnailStevia composition
Stevia compositions are prepared from steviol glycosides of stevia rebaudiana bertoni. The compositions are able to provide a superior taste profile and can be used as sweetness enhancers, flavor enhancers and sweeteners in foods, beverages, cosmetics and pharmaceuticals..
07/03/14
20140187761
 New steviol glycoside patent thumbnailNew steviol glycoside
Nobel stevia sweetening components are provided. Through the analysis of the components of the nobel steviol glycoside included in the stevia extract and/or crystals, not only the quality control of sweeteners, but judgment on the correctness of indication of origin or infringement of right are facilitated since the raw material of the sweetener can be identified..
07/03/14
20140187505
 Cardiac glycosides to treat cystic fibrosis and other il-8 dependent disorders patent thumbnailCardiac glycosides to treat cystic fibrosis and other il-8 dependent disorders
Disclosed is the use of a cardiac glycoside to decrease or inhibit the secretion of proinflammatory mediators in the treatment of disease conditions characterized by elevated levels of the proinflammatory mediator. The cardiac glycoside is administered to a mammalian subject in need of such treatment, and dosage is adjusted to the mass of the recipient and the need of the recipient to reduce or inhibit the level of the proinflammatory mediator.
07/03/14
20140186950
 Synthetic membrane anchors patent thumbnailSynthetic membrane anchors
Cells incorporating a synthetic molecule construct of the structure f—s1—s2-l where: f—s1 is an aminoalkylglycoside where f is a mono-, di-, tri- or oligo-saccharide and s1 is 2-aminoethyl, 3-aminopropyl, 4-aminobutyl, or 5-aminopentyl; s2 is —co(ch2)2co—, —co(ch2)3co—, —co(ch2)4co— or —co(ch2)5co—; and l is phosphatidylethanolamine.. .
07/03/14
20140186896
 Use of glycoside hydrolase 61 family proteins in processing of cellulose patent thumbnailUse of glycoside hydrolase 61 family proteins in processing of cellulose
The invention provides recombinant gh61 proteins obtained from myceliophtora thermophila, and nucleic acids that encode such proteins. The invention also provides protein fractions isolated from m.
06/26/14
20140179804
Stevia composition
Stevia compositions are prepared from steviol glycosides of stevia rebaudiana bertoni. The compositions are able to provide a superior taste profile and can be used as sweetness enhancers, flavor enhancers and sweeteners in foods, beverages, cosmetics and pharmaceuticals..
06/26/14
20140178923
Triclosan derivatives and uses thereof
A selective agent comprising a triclosan derivative for use in selective inhibition of non-target cells in a mixed population of target and non-target cells. Preferably the triclosan derivative is a glycoside derivative, more preferably a pyranoside derivative.
06/19/14
20140170083
Orally consumable formulations comprising certain sweet-tasting triterpenes and triterpene glycosides
The invention relates to triterpenes and triterpene glycosides of the formula (i) and/or physiologically acceptable salts thereof, preferably naturally occurring triterpenes and triterpene glycosides from mycetia balansae and/or physiologically acceptable salts thereof and orally consumable formulations comprising one or a plurality of these triterpenes and triterpene glycosides and/or physiologically acceptable salts thereof. The invention further relates to the use of these triterpenes and triterpene glycosides and/or physiologically acceptable salts thereof, preferably an extract of mycetia balansae, for generating a sweet impression in an orally consumable formulation or for reinforcing the sweet impression of an orally consumable formulation comprising at least one further, preferably naturally occurring, sweet-tasting substance.
06/12/14
20140162965
Compositions for oral drug administration
The present invention provides compositions and methods and for increasing the bioavailability of therapeutic agents in a subject. The compositions include at least one alkyl glycoside and at least one therapeutic agent, wherein the alkylglycoside has an alkyl chain length from about 10 to about 16 carbon atoms.
06/12/14
20140162323
Methods of combined bioprocessing and related microorganisms, thermophilic and/or acidophilic enzymes, and nucleic acids encoding said enzymes
A genetically modified organism comprising: at least one nucleic acid sequence and/or at least one recombinant nucleic acid isolated from alicyclobacillus acidocaldarius and encoding a polypeptide involved in at least partially degrading, cleaving, transporting, metabolizing, or removing polysaccharides, cellulose, lignocellulose, hemicellulose, lignin, starch, sugars, sugar oligomers, carbohydrates, complex carbohydrates, chitin, heteroxylans, glycosides, xylan-, glucan-, galactan-, or mannan-decorating groups; and at least one nucleic acid sequence and/or at least one recombinant nucleic acid encoding a polypeptide involved in fermenting sugar molecules to a product. Additionally, enzymatic and/or proteinaceous extracts may be isolated from one or more genetically modified organisms.
06/05/14
20140154752
Glycoside hydrolases having multiple hydrolase activities
Glycoside hydrolases having at least two different hydrolytic activities are provided. In one embodiment, an isolated recombinant hydrolase having at least two activities selected from a group including asparagine derivatives, glutamine derivatives, and histidine derivatives is provided.
05/29/14
20140148410
Supramolecular nanofibers and hydrogels based on nucleic acids functionalized with nucleobases
Disclosed are nucleopeptide compounds that include a nucleobase, and an amino acid. Certain compounds further comprise a glycoside.
05/29/14
20140148373
Cleaning compositions
A liquid cleaning composition containing alkyl polyglycoside surfactants, alkyl esters derived from vegetable oil, water and a sodium-containing base provides excellent cleaning soil removal capabilities. The carbon materials from which it is manufactured are all renewable, and the composition is readily biodegradable..
05/22/14
20140142201
Stevia composition
Stevia compositions are prepared from steviol glycosides of stevia rebaudiana bertoni. The compositions are able to provide a superior taste profile and can be used as sweetness enhancers, flavor enhancers and sweeteners in foods, beverages, cosmetics and pharmaceuticals..
05/22/14
20140142034
Unkown
The invention relates to a composition in aqueous solution, including insulin and at least one substituted anionic compound chosen from substituted anionic compounds consisting of a backbone formed from a discrete number u of between 1 and 8 (1≦u≦8) of identical or different saccharide units, linked via identical or different glycoside bonds, said saccharide units being chosen from the group consisting of hexoses, in cyclic form or in open reduced form, said compound comprising partially substituted carboxyl functional groups, the unsubstituted carboxyl functional groups being salifiable. The invention also relates to a pharmaceutical formulation comprising a composition as claimed in any one of the preceding claims..
05/08/14
20140128479
Absorption enhancers for drug administration
A composition including a surfactant and at least one alkyl glycoside and/or saccharide alkyl ester and a drug. The surfactant composition(s) when admixed with a drug is non-toxic and non-irritating, while stabilizing and increasing the bioavailability of the drug.
05/08/14
20140128384
Tumor targeted drug combretastatin a4 derivative
The present invention relates to imidazole, oxazole and thiazole derivatives of tumor-targeted drug combretastatin a4, and phosphate esters, sulfonate esters or pharmaceutically acceptable salts, glycoside derivatives, solvates thereof, wherein the a-ring comprises a 3,5-dimethoxyphenyl group having a substituent at the 4-position. The pharmacological activity assays have demonstrated that the compounds of the present invention have good in vitro anti-tumor activity and excellent tubulin inhibitory effect..
05/08/14
20140128331
C-glycoside derivatives
Wherein r1, r2, r3, r4, r5a, r5b, r5c and x are defined as in the description.. .
05/01/14
20140121177
Soyasapogenol composition
A soy saponin composition is provided high bodily absorption characteristics. In an embodiment, a soyasapogenol composition comprises soyasapogenol b and 3-o-d-glucuronopyranosyl soyasapogenol b.
05/01/14
20140120234
Chia seed composition
A composition of matter includes a shelf-stable, partially defatted supercritical co2 fluid solvent extracted whole grain flour derived from salvia hispanica l. Whole ground seed and that is free of cyanogenic glycosides, vitamin antagonists, and gluten.
04/24/14
20140113850
Novel use of heptylpolyglycosides for solubilising non-ionic surfactants in aqueous acidic cleaning compositions, and aqueous acidic cleaning compositions comprising same
A composition (c) of formula (i): r1—o-(g)p-h (i). G is a reducing sugar, r1 is a heptyl radical, p is a decimal number, and 1<p≦5.
04/24/14
20140113335
Improved cellulase variants
This invention provides novel variant cellulolytic enzymes having improved activity and/or stability. In certain embodiments the variant cellulotyic enzymes comprise a glycoside hydrolase with or comprising a substitution at one or more positions corresponding to one or more of residues f64, a226, and/or e246 in thermobifida fusca cel9a enzyme.
04/24/14
20140109466
Catalytic purification of fatty acid alkyl esters used in fuels
The process of this invention removes impurities from transesterification products comprising primarily fatty acid alkyl esters (faae) that are being processed for final fuel products, such as biodiesel. The inventive process is catalytic, and the resulting ester is suitable for use as biodiesel.
04/17/14
20140107145
Compositions for drug administration
The present invention provides compositions and methods and for increasing the bioavailability of therapeutic agents in a subject. The compositions include at least one alkyl glycoside and at least one therapeutic agent, wherein the alkylglycoside has an alkyl chain length from about 10 to about 16 carbon atoms..
04/10/14
20140099403
Methods for purifying steviol glycosides and uses of the same
Methods for purifying steviol glycosides, including rebaudioside x, are provided herein. Sweetener and sweetened containing rebaudioside x are also provided herein.
04/03/14
20140090840
Gravel pack carrier fluids
A method of gravel packing a hole in a subterranean formation having a filter cake coated on the surface thereof is disclosed. The method may include: injecting into the hole a gravel pack composition comprising gravel and a carrier fluid comprising a base fluid and at least one alkyl glycoside.
03/27/14
20140088056
Cardiac glycosides are potent inhibitors of interferon-beta gene expression
The invention provides for a method of inhibiting interferon-beta gene expression and/or reducing the level of interferon-beta in a cell by contacting the cell with a na+, ca2+, or k+ ion-channel modulator. The invention also provides for a method of treating a disease or disorder characterized by elevated interferon beta levels or elevated levels of interferon-beta gene expression.
03/27/14
20140087050
Chia seed composition
A composition of matter is disclosed and formed from a stable, defatted whole grain flour derived from salvia hispanica l. Whole ground seed using a suitable solvent that is free of cyanogenic glycosides, vitamin antagonists, and gluten.
03/20/14
20140080923
Stevia based sweetening composition
A liquid composition that includes at least one steviol glycoside dissolved in glycerol, and a method for preparation thereof, preferably at a temperature above 100° c. The steviol glycoside is extracted from stevia rebaudiana plant leaves.
03/20/14
20140080772
Treatments for melanoma
The present invention relates to mono- and combination therapies for melanoma, and in particular, metastatic melanoma. Drugs for use in such therapies in include ro 31-8220, bafetinib, and cardiac glycosides..
03/20/14
20140079870
Enhanced natural sweetener
A sweetening composition comprising stevia extract that contains steviol glycosides and other non-volatile components found in stevia leaves, wherein the steviol glycosides and other non-volatile components combined are less than about 80 wt % of the stevia extract.. .
03/06/14
20140066400
Glucosyl stevia composition
Glucosyl stevia compositions are prepared from steviol glycosides of stevia rebaudiana bertoni. The glucosylation was performed by cyclodextrin glucanotransferase using the starch as source of glucose residues.
03/06/14
20140066392
Combination treatments for melanoma
The present invention relates to combination therapies for melanoma, and in particular, metastatic melanoma. Drugs for use in such therapies in include braf inhibitors such as plx 4720 and plx 4734 in combination with ro 31-8220, bafetinib or cardiac glycosides..
03/06/14
20140065677
Novel glycoside hydrolases from thermophlic fungi
The present invention relates to isolated polypeptides having cellulolytic activity or hemicellulolytic activity and polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides..
02/27/14
20140058074
Use of 3,8,12,14, 17,20-oxo-substituted pregnene glycosides in the preparation of healthcare products, food additives and pharmaceuticals for the inhibition of appetite
The present invention relates to the use of 3,8,12,14,17,20-oxo-substituted pregnene glycosides having the following formula i in the preparation of healthcare products, food additives and drugs for losing body weight, controlling body weight and inhibiting appetite of human beings or animals, wherein, r1 is a saccharide group, and r2 is an acyl group.. .
02/20/14
20140051652
Treatment for migraine headache
Using a pharmaceutically suitable preparation containing one more cardio glycosides such as thevetin b, thevetin a, peruvoside, thevofolin, oleandrin, neriifolin, thevetoxin derived or extracted from the yellow oleandrin plant (oleandrin peruviana), white oleandrin plant (nerium oleander) and or other plants in the apocynaceae genus, in the dogbane plant family and or extracted from plants or animals including plants and animals such as foxglove or synthetic man-made, and or a combination of synthetic and natural thereof in pharmaceutically suitable preparation in a pharmaceutically suitable dose, example orally or intravenously, of which the prescriber of the said preparation, or doctor, based on the overall health of the patient will prescribe the best dosage, the best mode of dosage example orally or intravenously, which is best suited to have the most desirable therapeutic effect. .
02/20/14
20140051650
Vaginal compositions based on alkyl polyglucosides
Compounds based on alkyl polyglycosides for use in the treatment of streptococcus agalactiae infections and other pathogens are provided. Such compounds may belong to the class of alkyl glucosides or alkyl polyglucosides.
02/20/14
20140050703
Equol-producing lactic acid bacteria-containing composition
An equol-producing lactic acid bacteria-containing composition comprises, as an essential component thereof, a lactic acid bacterial strain belonging to the genus lactococcus having an ability to utilize at least one daidzein compound selected from the group consisting of daidzein glycosides, daidzein, and dihydrodaidzein to produce equol. Such a composition is effective for the prevention and alleviation of malaise inclusive of climacteric disturbance in middle-aged and elderly women for which no effective prophylactic method or alleviating means has heretofore been available..
02/13/14
20140045772
Cyclosporin compositions
A composition is disclosed herein comprising from about 0.001% to about 0.4% cyclosporin a, castor oil, and a surfactant selected from the group consisting of alcohol ethoxylates, alcohols, alkyl glycosides, alkyl polyglycosides, alkylphenol ethoxylates, amine oxides, block polymers, carboxylated alcohol or alkylphenol ethoxylates, carboxylic acids/fatty acids, cellulose derivatives, ethoxylated alcohols, ethoxylated alkylphenols, ethoxylated aryl phenols, ethoxylated fatty acids, ethoxylated fatty acids, ethoxylated fatty esters and oils, fatty alcohols, fatty esters, glycol esters, lanolin-based derivatives, lecithin and lecithin derivatives, lignin and lignin derivatives, methyl esters, monoglycerides and derivatives, phosphalipids, polyacrylic acids, polyethylene glycols, polyethylene oxide-polypropylene oxide copolymers, polyethylene oxides, polymeric surfactants, polypropylene oxides, propoxylated alcohols, propoxylated alkyl phenols, propoxylated fatty acids, protein-based surfactants, sarcosine derivatives, silicone-based surfactants, sorbitan derivatives, stearates, sucrose and glucose esters and derivatives, and combinations thereof.. .
02/13/14
20140044843
Methods of producing sweet juice compositions
The present disclosure relates to methods of producing a sweet juice composition from monk fruit and other fruit of the cucurbitaceae family containing mogroside v and other terpene glycosides. The methods employ a cation exchange resin and an anion exchange resin to obtain a sweet juice composition with a clean flavor.
02/13/14
20140041654
Method for treatment of lung infections by administration of aminoglycosides by aerolisation
The present invention regards a novel administration form and a novel administration regime useful in the treatment and prevention of a bacterial lung infection in patient in need thereof, in particular by providing a composition useful for aerosolization of a highly concentrated solution of aminoglycosides such as tobramycin.. .
02/06/14
20140038915
Methods for treating bacterial infection
This invention relates to methods for treating bacterial infection, which methods find utility in the treatment of, for example, infected ulcers, optionally infected diabetic ulcers. In particular, this invention relates to treating bacterial infection, for example, infected diabetic ulcers by topical administration of at least one aminoglycoside antibiotic at the site of infection, in combination with at least one antibacterial agent, which antibacterial agent is administered remote from the site of infection, preferably administered systemically.
02/06/14
20140038914
Compounds for use in the treatment of bacterial infection
Or a pharmaceutically acceptable salt thereof; wherein r1 to r4, r7, r9 to r12 and y are as defined herein. The invention further relates to pharmaceutical composition comprising said compound or a pharmaceutically acceptable salt thereof; and method of using same for reducing or reversing bacterial resistance to at least one aminoglycoside antibiotic..
01/30/14
20140030381
Glucosyl stevia composition
Glucosyl stevia compositions are prepared from steviol glycosides of stevia rebaudiana bertoni. The glucosylation was performed by cyclodextrin glucanotransferase using the starch as source of glucose residues.
01/23/14
20140023750
Glucosylated steviol glycosides composition as a flavor modifier
A taste and flavor profile enhancing composition includes glucosylated steviol glycosides which can enhance the intensity of a taste and/or a flavor in a food or beverage product. A method of increasing the taste and flavor intensity of a food or beverage product, includes the step of adding a taste and flavor enhancing composition to the food or beverage product, wherein the taste and flavor enhancing composition includes glucosylated steviol glycosides.
01/23/14
20140023606
Process for producing a conditioning cleaning agent
A process for producing a conditioning cleaning agent includes a) providing a microemulsion including (i) at least one alkyl(oligo)glycoside, (ii) at least one ester of glycerin with at least one c10-c24 fatty acid, (iii) at least one oil which is different from (ii), and (iv) water, and b) mixing the microemulsion with a cosmetic carrier that includes at least one polyhydroxy compound of formula (i) as defined in the specification herein.. .
01/23/14
20140023605
Process for producing a conditioning cleaning agent
A process for producing a conditioning cleaning agent includes the steps of: a) providing a microemulsion, containing (i) at least one alkyl(oligo)glycoside, (ii) at least one ester of glycerin with at least one c10-c24 fatty acid, (iii) at least one oil which is different from (ii), and (iv) water, and b) mixing the microemulsion with a cosmetic carrier that contains at least one protein hydrolysate.. .


Popular terms: [SEARCH]

Glycoside topics: Rebaudioside, Steviol Glycosides, Osteoporosis, Steoporosis, Aminoglycoside, Adsorption, Crystallin, Liquid Fraction, Critical Point, Chromatograph, Alkoxylate, Alkyl Group, Cycloalkyl, Vitamin D3, Osteopenia

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Glycoside for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Glycoside with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.1899

3450

1 - 1 - 73